Targeting tumor transition windows

Area of Science:

• Oncology
• Cancer Biology
• Genomics

Background:

• Tumor heterogeneity and cellular plasticity drive cancer treatment failure.
• Precision oncology traditionally focuses on static genomic alterations, overlooking dynamic tumor adaptation.
• Tumors can transition between functional states under therapeutic pressure, developing drug tolerance.

Purpose of the Study:

• To review how temporal tumor dynamics and cellular plasticity influence treatment response.
• To explore mechanisms of tumor adaptation, including epigenetic reprogramming and metabolic rewiring.
• To examine the therapeutic potential of targeting transient adaptive states.

Main Methods:

• Synthesis of findings from tumor plasticity, drug-tolerant persister biology, and adaptive therapy research.
• Analysis of emerging evidence on short-lived cellular instability during therapy.
• Review of advances in single-cell transcriptomics, epigenomics, and ctDNA analysis for monitoring tumor transitions.

Main Results:

• Tumors exhibit dynamic adaptation during therapy, transitioning through transient states before stabilizing resistance.
• These adaptive states involve altered molecular dependencies and survival programs.
• Therapeutic actionability of transition states requires functional evidence of altered drug sensitivity or pathway dependence.

Conclusions:

• Targeting transient adaptive states presents a potential strategy to overcome therapeutic failure.
• Longitudinal monitoring using advanced multi-omics and imaging can identify these critical transition states.
• Integrating temporal tumor biology with adaptive treatment strategies may refine precision oncology.